FDA Drug Application (078183) for CIPROFLOXACIN EXTENDED RELEASE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number078183
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage212.6MG;EQ 287.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCIPROFLOXACIN EXTENDED RELEASE
Active IngredientCIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient CIPROFLOXACIN10
List of drugs with Active Ingredient CIPROFLOXACIN HYDROCHLORIDE9


Back to FDA Applications sponsored by MYLAN PHARMS INC